.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Matthew T. Bush
Matthew T. Bush

Matthew T. Bush

Partner at Latham & Watkins

Lawyer

San Diego

Deal Bio

Total Deals16
Valued Deals14
Total Value£13,185M
Avg. Deal Size£942M

Expertise (16)

Key Relationships

United States
Distillers and Vintners
PrivateAcquisition
Home Brew Mart

target

Home Brew Mart

Constellation Brands

bidder

Constellation Brands

value n/a

3 dealmakers

United States
Biotechnology
PrivateAcquisitionPrivate Equity
Open Monoclonal Technology

target

Open Monoclonal Technology

Ligand Pharmaceuticals

bidder

Ligand Pharmaceuticals

value n/a

2 dealmakers

United States
Health Care Services
PrivateAcquisitionPrivate Equity
Zavante Therapeutics Inc.

target

Zavante Therapeutics Inc.

Nabriva Therapeutics

bidder

Nabriva Therapeutics

£93m

2 dealmakers

United KingdomUnited Kingdom
Pharmaceuticals
PublicScheme
Vernalis

target

Vernalis

Ligand Pharmaceuticals

bidder

Ligand Pharmaceuticals

£6m

12 dealmakers

France
Medical Services
MajorityPublicAcquisitionTender Offer
Eos Imaging

target

Eos Imaging

Alphatec Holdings

bidder

Alphatec Holdings

£94m

10 dealmakers

United States
Biotechnology
PrivatePrivate EquityVenture CapitalAcquisitionMinority
ERASCA

target

ERASCA

Arch Venture Partners

bidder

Arch Venture Partners

£161m

22 dealmakers

United States
Biotechnology
DomesticPublicAcquisitionTender OfferMajority
Pfenex

target

Pfenex

Ligand Pharmaceuticals

bidder

Ligand Pharmaceuticals

£349m

13 dealmakers

France
Medical Services
AcquisitionMajorityPrivate EquityCross BorderTender OfferPublic
Eos Imaging

target

Eos Imaging

Squadron Capital

bidder

Squadron Capital

£87m

12 dealmakers

United States
Mobile
Venture CapitalAcquisitionPrivateCross BorderPrivate EquityMinority
Tealium

target

Tealium

GEORGIAN

bidder

GEORGIAN

£70m

11 dealmakers

United States
Biotechnology
AcquisitionDomesticReverse TakeoverPrivateDe-SPACPrivate EquityMajority
Effector Therapeutics

target

Effector Therapeutics

Locust Walk Acquisition Corp

bidder

Locust Walk Acquisition Corp

£296m

33 dealmakers

United States
Pharmaceuticals
Tender OfferAcquisitionCross BorderMajorityPublicPrivatisation
Zogenix

target

Zogenix

Ucb Pharma

bidder

Ucb Pharma

£1,395m

56 dealmakers

United States
Biotechnology
Spin OffAcquisitionMajorityDomesticPrivateDe-SPACPrivate EquityReverse Takeover
Omniab

target

Omniab

Avista Public Acquisition Corp Ii

bidder

Avista Public Acquisition Corp Ii

£643m

36 dealmakers

United States
Biotechnology
DomesticAcquisitionMajorityPublic
Prometheus Biosciences

target

Prometheus Biosciences

Merck & Co

bidder

Merck & Co

£8,698m

50 dealmakers

United States
Medical Services
AcquisitionCross BorderMajorityTender OfferPublic
Icosavax

target

Icosavax

ASTRAZENECA

bidder

ASTRAZENECA

£876m

27 dealmakers

Ireland
Medical Equipment
AcquisitionMinorityPrivate EquityCross BorderPrivateVenture Capital
Mainstay Medical Holdings

target

Mainstay Medical Holdings

Gilde Healthcare

bidder

Gilde Healthcare

£98m

7 dealmakers

United States
Pharmaceuticals
Venture CapitalMinorityPrivateAcquisitionDomesticPrivate Equity
Mirador Therapeutics

target

Mirador Therapeutics

Orbimed Advisors

bidder

Orbimed Advisors

£314m

7 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US